A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
Recruiting · NCT06240728 · Registry updated 2025-06-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasm | Recruiting | Phase 1 | 2025-06-27 | NCT06240728 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NextPoint Therapeutics, Inc. | 2 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Albert Einstein Medical College Montefiore Medical Center | The Bronx | United States | 1 |
| Beth Israel Deaconess Medical Center (Bidmc) | Boston | United States | 14 |
| Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center | Baltimore | United States | 1 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| NEXT Oncology | San Antonio | United States | 70 |
| NEXT Oncology-Fairfax | Fairfax | United States | 1 |
| Samsung Medical Center | Seoul | South Korea | 375 |
| Severance Hospital, Yonsei University Health System | Seoul | South Korea | 134 |